Evidence map›Paper›PMID 31286109›Full record

ArticleJournal of the Endocrine Society2019

Long-Acting and Selective Oxytocin Peptide Analogs Show Antidiabetic and Antiobesity Effects in Male Mice.

Brandy Snider, Andrea Geiser, Xiao-Peng Yu, Emily Cathleen Beebe, Jill Amanda Willency, Keyun Qing, Lili Guo, Jianliang Lu, Xiaojun Wang, Qian Yang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Ameliorative Effect of Oxytocin onFrontiers in public health · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Oxytocin as an Anti-obesity Treatment.Frontiers in neuroscience · 2021
    Review
  16. Article
  17. Metabolic Effects of Oxytocin.Endocrine reviews · 2020
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Brandy SniderDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Andrea GeiserBiotechnology Peptide Group, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Xiao-Peng YuDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Emily Cathleen BeebeDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.ORCID 0000-0002-4629-4281
Jill Amanda WillencyDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Keyun QingDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Lili GuoBiotechnology Peptide Group, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Jianliang LuMedicinal Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Xiaojun WangDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Qian YangDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Alexander EfanovDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Andrew Charles AdamsDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Tamer CoskunDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Paul Joseph EmmersonDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Jorge Alsina-FernandezBiotechnology Peptide Group, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Minrong AiDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.ORCID 0000-0002-2531-7958
Eli Lilly (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxytocin (OXT) has been shown to suppress appetite, induce weight loss, and improve glycemic control and lipid metabolism in several species, including humans, monkeys, and rodents. However, OXT's short half-life in circulation and lack of receptor selectivity limit its application and efficacy. In this study, we report an OXT peptide analog (OXT

Indexed as

acylationoxytocinvasopressinweight loss

Identifiers

PMID31286109
PMCPMC6608564
OpenAlexW2946419846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.